Ark Invest Cathie Wood performs Tempus AI, Archer Aviation, but it sells Twist BiScience: Here are main coffin deals on Friday – Archer Aviation (Nyse: Achr), Accolade (Nasdaq: AcCD)

Friday, February 28, 2025, Cathy Woods Ark Invest Make some prominent deals. The most prominent of these purchases Artcher Aviation Achrand The return of medicines Rxrxand Tempus ai Inc TimAnd Iridium Communications Inc Irdm.
On the other hand, Ark Invest decided to cancel shares download Test Biological Sciences Environment Twstand I condemn Nev Makeand Accolade Inc ACCDAnd Define Science Company Exas.
Achr Trade
ARK Invest bought a large number of shares in Artcher Aviation Three of the traded investment funds. the Ark Innovation Etf ARKK Buy 360,583 shares, Ark Technology & Robotics Etf ARKQ I got 54,699 shares, and Ark Space Explography & Innovation ETF ARKX 17322 shares added.
Based on the closing price of $ 8.88 on Friday, the total value of these deals is about $ 3.8 million.
RXRX and Tem deals
ARK Invest also showed strong interest in Recursion Pharmaceuticals Inc and Tempus AI Inc. ARK Invest, previously bought a large number of shares in Tempus AI despite the decrease in the company’s shares after reporting the mixed results in the fourth quarter.
Ark Invest’s Jinnote ARKG Bought 268,467 shares of Recursion Pharmaceuticals and 32,467 shares from Tempus AI.
ARK Innovation ETF acquired 384,956 arrows of repeated drugs and 49,250 shares of Tempus AI.
Looking at the closing prices of $ 56.18 for TEMPUS AI and $ 7.51 for the drug relationship, the total value of these deals is $ 36.7 million and $ 0.61 million, respectively.
The Irdm, Twyey, AcCD and Exas
Ark Invest’s Ark Innovation ETF 73,659 has bought share of IRIDIUM Communications Inc, while selling 65,290 shares of Twist Bioscience Corp.
ETF Ark Next Internet ETF has sold a small number of shares (52) of Adeen NV.
ETF has sold the genetic revolution ARK 80,270 shares from Sciences Corp and a simple amount (232) of Accolade Inc. shares.
Read the following:
Slip: This content was partially produced with the help of artificial intelligence tools and was reviewed and published by Beenzinga editors.
Photo via Ark Invest
Market news and data brought to you benzinga Apis
© 2025 benzinga.com. Benzinga does not provide investment advice. All rights reserved.